Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2005
03/09/2005CN1192102C Enzyme catalyzed therapeutic agents
03/09/2005CN1192097C Multi-array, multi-specific electrochemiluminescence testing
03/09/2005CN1192037C Signal sequence for production of leu-hirudine via secretion by E coli in culture medium
03/08/2005US6865491 Method for sequencing polynucleotides
03/08/2005US6864364 MinK-related genes, formation of potassium channels and association with cardiac arrhythmia
03/08/2005US6864358 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor
03/08/2005US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
03/08/2005US6864229 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same
03/08/2005US6864227 Artery-and vein-specific proteins and uses therefor
03/08/2005US6864224 Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth
03/08/2005US6864103 Such as hydroxyisophthamidylamide-based bidentate ligands; bioavailiable probes for use in immunoassay
03/08/2005US6864102 Device for performing an assay, a method for manufacturing said device, and use of a membrane in the manufacture of said device
03/08/2005US6864100 Automated protein purification the multiwell format by vacuum filtration
03/08/2005US6864099 Attaching first and second isotopic variants of chemical moiety to protein in first and second samples, subjecting mixture to mass spectrometric analysis to determine difference in concentration in samples
03/08/2005US6864097 Arrays and their reading
03/08/2005US6864093 Method of identifying and treating invasive carcinomas
03/08/2005US6864076 Protein for use in the prevention of fungal infection
03/08/2005US6864073 Avermectin aglycon synthase genes
03/08/2005US6864071 Accumulation of preferential nucleotide sequences; obtain nucleotide sequences, incubate with probes and primers, ligate terminals, propagate amplicons and recover sequences
03/08/2005US6864070 Polypeptide for use in the treatment of vision defects and psychological disorders
03/08/2005US6864067 Compositions and methods for regulating bacterial pathogenesis
03/08/2005US6864064 18891, a novel human lipase
03/08/2005US6864061 Detecting modulators of anti-inflammatory activity; obtain cells, incubate with modulator, monitor adjustment in inflammatory activity
03/08/2005US6864059 Coupling a nucleic acid labeling compound (a biotin compound attached to a nucleic acid base derivative containing triphosphate) with a nucleic acid
03/08/2005US6864058 Vaccinia topoisomerases I-based assays for detection of specific DNA breaks
03/08/2005US6864056 Method for detecting ribosome inactivating proteins
03/08/2005US6864055 Method for detecting nucleic acids
03/08/2005US6864053 Quantitative assay of host cell DNA in a sample
03/08/2005US6864052 Enhanced sequencing by hybridization using pools of probes
03/08/2005US6864050 Single-phase amplification of nucleic acids
03/08/2005US6864049 Consists contacting a first nucleic acid molecule with a second nucleic acid molecule under conditions enabling the formation of a specific hybridization complex
03/08/2005US6863892 Diagnosi and treatment of cancer; obtain tissue sample, monitor gene expression in sample, monitor methylation in sample, compare to control, evaluate for cancer
03/08/2005US6863880 Methods to diagnose a required regulation of trophoblast invasion
03/08/2005US6863801 Biosensor such as for determining glucose concentration in blood
03/08/2005US6863800 Determination glucose concentration in blood
03/08/2005US6863196 Apparatus for hanging hats
03/08/2005CA2262776C Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
03/03/2005WO2005020125A2 Methods and systems for profiling biological systems
03/03/2005WO2005019832A2 Quantification and site-specific profiling of protein phosphorylation
03/03/2005WO2005019831A2 Methods for reducing complexity of a sample using small epitope antibodies
03/03/2005WO2005019829A1 Inhibition of s6 kinase activity for the treatment of insulin resistance
03/03/2005WO2005019801A2 Method for rapid identification of molecules with functional activity towards biomolecular targets
03/03/2005WO2005019795A2 Electrochemical sensors including electrode systems with increased oxygen generation
03/03/2005WO2005019479A1 A quantification method for integrated viruses
03/03/2005WO2005019478A1 Methods and compositions for modulating herpesviral replication and transcription activator
03/03/2005WO2005019477A2 Methods and compositions for differentiating tissues or cell types using epigenetic markers
03/03/2005WO2005019476A1 Polymerase compositions
03/03/2005WO2005019475A2 Hypoxia-inducible protein 2 (hig2), a novel therapeutic potential target of renal cell carcinoma (rcc)
03/03/2005WO2005019474A2 Human autism susceptibility gene and uses thereof
03/03/2005WO2005019473A2 Use of silver gene for the authentication of the racial origin of animal populations, and of the derivative products thereof
03/03/2005WO2005019472A1 Method of detecting effect of controlling synoviolin activity
03/03/2005WO2005019469A2 Rna detection and quantitation
03/03/2005WO2005019457A2 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
03/03/2005WO2005019447A1 Monochromatic fluorescent probe
03/03/2005WO2005019433A2 VIRALLY-ENCODED RNAs AS SUBSTRATES, INHIBITORS AND DELIVERY VEHICLES FOR RNAi
03/03/2005WO2005019430A2 In vitro selection of aptamer beacons
03/03/2005WO2005019427A2 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals
03/03/2005WO2005019426A2 Gene cluster for fostriecin biosynthesis
03/03/2005WO2005019423A2 Methods and compositions comprising fatp5 for use in the diagnosis and treatment of metabolic disorders
03/03/2005WO2005019419A2 Co-detection of single polypeptide and polynucleotide molecules
03/03/2005WO2005019413A2 A low maintenance detector for biological agents
03/03/2005WO2005019410A2 Rnai agents for anti-sars coronavirus therapy
03/03/2005WO2005019409A2 Combinatorial protein library screening by periplasmic expression
03/03/2005WO2005019268A1 Novel antibody against cancer antigen
03/03/2005WO2005019259A2 Variants of interleukin-1 receptor antagonist: compositions and uses thereof
03/03/2005WO2005019251A2 Novel fungal proteins and nucleic acids encoding same
03/03/2005WO2005019249A2 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
03/03/2005WO2005019248A1 Hiv immunogenic complexes
03/03/2005WO2005019235A2 Use of novel compounds to release nucleotides from living cells
03/03/2005WO2005019136A2 Methods and compositions for degradation of nitroaromatic and nitramine pollutants
03/03/2005WO2005018673A1 Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiocascular disease caused thereby
03/03/2005WO2005018436A2 Methods for the diagnosis, prognosis and treatment of metabolic syndrome
03/03/2005WO2005018431A2 Compositions and methods for detecting and treating neurological conditions
03/03/2005WO2005018423A2 Pna oligomers, oligomer sets, methods and kits pertaining to the determination of enterococcus faecalis and other enterococcus species
03/03/2005WO2005018414A2 Detection of somatic cells in milk
03/03/2005WO2005005977A3 Fluorescent phospholipase assays and compositions
03/03/2005WO2005005652A3 Methods for the identification of inhibitors of c4 long chain base hydroxylase activity in plants
03/03/2005WO2005000088A3 Expression profile of pancreatic cancer
03/03/2005WO2004106891A3 Ultrasensitive biochemical sensor
03/03/2005WO2004106554A3 Primase dna templates
03/03/2005WO2004106536A3 Diagnostics and therapeutics for diseases associated with serine protease 8 (prss8)
03/03/2005WO2004104216A3 Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4)
03/03/2005WO2004104211A3 Method for detecting toxic and non-toxic cyanobacteria
03/03/2005WO2004098647A3 Claudins’ underexpression as markers of tumor metastasis
03/03/2005WO2004094668A3 Oligonucleotide pairs for multiplexed binding assays
03/03/2005WO2004094667A3 Reagents and methods for detecting severe acute respiratory syndrome coronavirus
03/03/2005WO2004092412A3 Compositions and methods for detecting certain flaviviruses, including members of the japanese encephalitis virus serogroup
03/03/2005WO2004092408A3 Oligonucleotides for the detection of salmonella species
03/03/2005WO2004092404A3 Inhibitors of acidic mammalian chitinase as asthma therapeutics
03/03/2005WO2004092325A3 Screening methods using zebrafish to identify thrombotic and anti-thrombotic compounds and genes
03/03/2005WO2004091476A3 Method of screening remedy for heart disease and medicinal composition for treating heart disease
03/03/2005WO2004090104A3 Detecting gene expression in live cells using short-lived reporters with enzymatic amplification
03/03/2005WO2004085480A3 Process and composition for assaying carbohydrates
03/03/2005WO2004081563A3 Diagnostics and therapeutics for diseases associated with phosphodiesterase 1a (pde1a)
03/03/2005WO2004075835A3 Methods for the treatment of renal cell carcinoma
03/03/2005WO2004072269A9 Bex4 nucleic acids, polypeptides, and method of using
03/03/2005WO2004072265A3 Methods for monitoring drug activities in vivo
03/03/2005WO2004065583A3 Gene expression markers for breast cancer prognosis
03/03/2005WO2004063962A3 Linkage analysis using direct and indirect counting
03/03/2005WO2004059001A3 Method for determining markers of human facial skin